Drug Trial Radar · NCT04567667
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants
Last checked: Nov 19, 2026Latest source record: Jun 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9
Actual
Start
Oct 15, 2020
Primary completion
Apr 11, 2021
Study completion Apr 11, 2021
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Sep 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the way the body absorbs, distributes, breaks down and eliminates radioactive BMS-986278 as well as the safety and tolerability of BMS-986278 in healthy male participants.
Conditions
- Healthy Volunteers
Interventions
[14C] BMS-986278Drug
Specified dose on specified days
Kinevac®Drug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum observed plasma concentration (Cmax) of BMS-986278Time frame: Up to 15 days
- Maximum observed plasma concentration (Cmax) of total radioactivity (TRA)Time frame: Up to 15 days
- Time of maximum observed plasma concentration (Tmax) of BMS-986278Time frame: Up to 15 days
- Time of maximum observed plasma concentration (Tmax) of TRATime frame: Up to 15 days
- Area under the plasma concentration-time curve extrapolated to infinity (AUC(INF)) of BMS-986278Time frame: Up to 15 days
- Area under the plasma concentration-time curve extrapolated to infinity (AUC(INF)) of TRATime frame: Up to 15 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Covance - Clinical Pharmacology Services - Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.